# A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

> **NCT01171092** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Malignant Lymphoma, Stem Cell Type
- Autologous Transplant

## Interventions

- **DRUG:** bortezomib and G-CSF

## Key facts

- **NCT ID:** NCT01171092
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-01
- **Final completion:** 2014-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171092, "A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01171092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*